KRT18P17: A Potential Drug Target and Biomarker (G344866)

Target Name: KRT18P17

NCBI ID: G344866

KRT18P17

Other Name(s): keratin 18 pseudogene 17 | Keratin 18 pseudogene 17

KRT18P17: A Potential Drug Target and Biomarker

Keratin is a protein that plays a crucial role in the structure and function of hair and nails. It is composed of multiple genes, including KRT18P17, which has been identified as a potential drug target and biomarker for various diseases. In this article, we will explore the biology of KRT18P17 and its potential as a drug target.

The KRT18P17 gene is located on chromosome 16p11.2 and encodes a 21-kDa protein that is involved in the production of the protein keratin-related protein 18 (KRT18). KRT18 is a key component of the hair and nail growth cycle and plays a vital role in the development and maintenance of these structures.

KRT18P17 has been shown to be involved in various cellular processes that are important for hair and nail growth. For example, it has been shown to be involved in the regulation of cell cycle progression, cell adhesion, and the distribution of organelles in the cell. It has also been shown to play a role in the development and maintenance of the cuticle, the outer layer of the hair, and the nail matrix.

In addition to its role in hair and nail growth, KRT18P17 has also been shown to be involved in the regulation of diseases that affect these structures, such as scalp psoriasis, dandruff, and nail fungus. It has been shown to be involved in the development of these conditions by contributing to the abnormal growth and differentiation of cells that occur in the affected areas.

As a result of its involvement in these processes, KRT18P17 has been identified as a potential drug target for a variety of diseases. For example, studies have shown that inhibiting the activity of KRT18P17 has the potential to treat scalp psoriasis by reducing the growth of abnormal cells in the affected area. Similarly, studies have shown that inhibiting the activity of KRT18P17 has the potential to treat dandruff by reducing the growth of yeast cells that cause the condition.

In addition to its potential as a drug target, KRT18P17 has also been identified as a potential biomarker for various diseases. For example, studies have shown that increased levels of KRT18P17 have been associated with the development of certain types of cancer, including breast and prostate cancer. Similarly, high levels of KRT18P17 have also been associated with the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

In conclusion, KRT18P17 is a protein that plays a crucial role in the structure and function of hair and nails. It has been shown to be involved in various cellular processes that are important for this structure and function. In addition to its role in hair and nail growth, KRT18P17 has also been shown to be involved in the regulation of diseases that affect these structures. As a result, it has potential as a drug target and biomarker for various diseases. Further research is needed to fully understand the role of KRT18P17 in these processes and its potential as a drug.

Protein Name: Keratin 18 Pseudogene 17

The "KRT18P17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT18P17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets